國家衛生研究院 NHRI:Item 3990099045/15516
English  |  正體中文  |  简体中文  |  Items with full text/Total items : 12145/12927 (94%)
Visitors : 906723      Online Users : 938
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
  • Adv. Search
    HomeLoginUploadHelpAboutAdminister Goto mobile version
    Please use this identifier to cite or link to this item: http://ir.nhri.org.tw/handle/3990099045/15516


    Title: Therapeutic effects of gnmt inducers for non-alcoholic fatty liver disease and hepatocellular carcinoma
    Authors: Chen, Y
    Contributors: National Institute of Infectious Diseases and Vaccinology
    Abstract: Background: Glycine-N-methyl transferase (GNMT) downregulation results in nonalcoholic fatty liver disease (NAFLD) and spontaneous hepatocellular carcinoma (HCC) both. Overexpression of GNMT inhibits the accumulation of lipid in hepatocytes, the proliferation of liver cancer cell lines and prevents carcinogen-induced HCC, suggesting that GNMT induction is potential approaches for anti-NAFLD and anti-HCC therapy. Methods: Herein, we used Huh7 GNMT promoter-driven screening to identify two GNMT inducers from natural plant extracts library and small molecule library. First, 1,2,3,4,6-pentagalloyl glucose (PGG) was identified from the extract of Paeonia lactiflora Pall (PL). Second, compound K78 was identified and validated for its induction of GNMT and inhibition of Huh7 cell growth. Subsequently, we employed structure−activity relationship analysis and found a potent GNMT inducer, K117. The GNMT expression was further confirmed by reverse transcription-quantitative PCR (RT-qPCR) and Western blotting (WB) analysis using both in vitro and in vivo systems. Results: PGG and metformin were shown to upregulate liver mitochondrial GNMT protein expression. The high-fat diet (HFD)-induced NAFLD mice were treated with PGG and metformin. The combination of PGG and metformin nearly completely reversed weight gain, elevation of serum aminotransferases, and hepatic steatosis and steatohepatitis. In addition, the downregulated GNMT expression in liver tissues of HFD-induced NAFLD mice was restored. On the other hand, K117 inhibited Huh7 cell growth in vitro and xenograft in vivo. Oral administration can inhibit Huh7 xenograft in a manner equivalent to the effect of sorafenib. A mechanistic study revealed that both PGG and K117 are MYC inhibitors. Ectopic expression of MYC using CMV promoter blocked PGG- and K117-mediated MYC inhibition and GNMT induction. Conclusion: Our findings show that GNMT expression plays an important role in the pathogenesis of NAFLD and HCC, PGG and K117 are potential compounds for NAFLD-, HCC- and MYC-dependent cancers.
    Date: 2023-10
    Relation: Hepatology. 2023 Oct;78(Suppl. 1):S1903.
    Link to: http://dx.doi.org/10.1097/HEP.0000000000000580
    JIF/Ranking 2023: http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=NHRI&SrcApp=NHRI_IR&KeyISSN=0270-9139&DestApp=IC2JCR
    Cited Times(WOS): https://www.webofscience.com/wos/woscc/full-record/WOS:001094865404407
    Appears in Collections:[Others] Conference Papers/Meeting Abstract

    Files in This Item:

    File SizeFormat
    ISI001094865404407.pdf155KbAdobe PDF52View/Open


    All items in NHRI are protected by copyright, with all rights reserved.

    Related Items in TAIR

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback